Rickettsial antibodies in multiple sclerosis.
The serum of subjects with multiple sclerosis or other degenerative neurological diseases and that of normal controls does not differ significantly in its content of antibodies to several rickettsial antigens. There is no evidence for a rickettsial aetiology of multiple sclerosis, and no grounds for an extended clinical trial of Le Gac's full method of treatment with antibiotics.
D000328:Adult; D000372:Agglutination Tests; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000906:Antibodies / Q000032:analysis*; D000941:Antigens; D003381:Coxiella / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology; D012281:Rickettsia / Q000276:immunology*; D012283:Rickettsia prowazekii / Q000276:immunology; D012286:Rickettsia typhi / Q000276:immunology
D000900:Anti-Bacterial Agents; D000906:Antibodies; D000941:Antigens